Results
1 -
10 of
12Treatment of Chronic Lymphocytic Leukemia and Related Disorders, Neoplastic Diseases of the Blood Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia, Annals of Hematology Distinct roles for phosphoinositide 3-kinases ?? and ?? in malignant B cell migration, Leukemia PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia, Current Hematologic Malignancy Reports ASH 2014 highlights: new therapeutic concepts for T cell lymphomas, memo - Magazine of European Medical Oncology Chronic lymphocytic leukemia: ASH update 2014, memo - Magazine of European Medical Oncology The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL), Current Hematologic Malignancy Reports The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date, Drugs Prediction of Tumor-to-Plasma Ratios of Basic Compounds in Subcutaneous Xenograft Mouse Models, European Journal of Drug Metabolism and Pharmacokinetics Duvelisib, Reactions Weekly